Role of Postoperative Radiotherapy Based on Epidermal Growth Factor Receptor Gene Status in Patients with Pathological Stage Ⅲ-N2 Non-Squamous Carcinoma Lung Cancer: A Propensity Score-Matched Analysis

Abstract

>50% and unknown in 5, 1 and 1 patients, respectively. There was 1 complete response, 1 partial response, 3 with stable disease, 2 with disease progression. No treatment related toxicities of grade 3 occurred. Conclusion: The trial continues enrollment. Updated results and immunological correlates will be presented at ASTRO.